FDA approves enoxaparin sodium injection for STEMI.
D017277:Drug Approval; D017984:Enoxaparin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents; D006801:Humans; D007267:Injections; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D055502:Secondary Prevention; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D017984:Enoxaparin; D005343:Fibrinolytic Agents